Every 10-Q that AdvanSix Inc. (ASIX) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow ASIX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ASIX filings page.
AdvanSix reported Q2 2026 sales of $421,284 thousand, up 2.7% year over year, but net income fell to $3,248 thousand. For the first half, sales reached $825,468 thousand while the company recorded a net loss of $(12,298) thousand and gross margin compressed to 4.2% from 14.2%.
Cost of goods sold rose 17.0% in the first half, driven by higher benzene, sulfur and propylene prices, increased plant and utility costs, winter-storm expenses and the absence of $26 million of insurance proceeds recognized a year earlier. Adjusted EBITDA declined to $36,644 thousand from $107,301 thousand, and Adjusted EBITDA Margin fell to 4.4% from 13.6%.
Operating cash flow turned negative at $(5,294) thousand versus $32,553 thousand a year ago, as AdvanSix funded $56,650 thousand of capital expenditures and increased revolver borrowings to $275,000 thousand, leaving approximately $224 million of availability and $7,217 thousand of cash. The company maintained a $0.16 per‑share quarterly dividend and has about $62.0 million of remaining share‑repurchase authorization, with repurchases currently paused. A goodwill impairment test was triggered by a sustained market‑capitalization decline, but no impairment was recorded.
AdvanSix Inc. reported a weaker first quarter of 2026, moving from profit to loss despite higher sales. Revenue rose to $404.2 million from $377.8 million, driven mainly by about 6% higher volumes and modest pricing gains, especially in Plant Nutrients and Chemical Intermediates.
The company posted a net loss of $15.5 million, or $(0.58) per diluted share, compared with net income of $23.3 million, or $0.86 per diluted share, a year earlier. Gross margin compressed sharply to 0.9% from 14.2%, as higher sulfur and utility costs, winter storm expenses, and the absence of $26 million of prior-year insurance proceeds outweighed pricing benefits.
Adjusted EBITDA fell to $4.8 million, a 1.2% margin, from $51.6 million and a 13.7% margin. Operating cash flow was a use of $15.3 million versus $11.4 million provided in the prior year, reflecting lower earnings partly offset by working capital improvements. At quarter-end, cash was $17.6 million and revolver borrowings were $270 million, leaving about $229 million of additional capacity. The company paid a $0.16 per-share dividend in March and the board declared another $0.16 dividend payable June 2, 2026.
AdvanSix (ASIX) reported a Q3 2025 net loss of $2.6 million (diluted EPS -$0.10) on sales of $374.5 million, down 6% year over year. Results reflected softer demand in nylon and chemical intermediates, lower raw-material pass-through pricing, and higher utilities, sulfur and natural gas costs, which compressed gross margin to 6.8% from 14.4%.
Year to date, sales were $1.16 billion with net income $52.1 million, helped by $26 million in business-interruption insurance proceeds recognized earlier this year and lower interest expense. Plant Nutrients remained a relative bright spot: in Q3 it represented $138.7 million (37%) as North American ammonium sulfate conditions stayed favorable.
Operating cash flow was $59.1 million for the first nine months, capex $88.8 million, and cash ended at $23.7 million. The company amended its revolver, extending $452 million of the $500 million facility to October 27, 2027, with the remaining $48 million maturing in 2026. The Board declared a $0.16 dividend payable December 2, 2025. Adjusted EBITDA for Q3 was $24.7 million (margin 6.6%), down from 13.4% a year ago.